THRD
Third Harmonic Bio Inc.
NASDAQ: THRD · HEALTHCARE · BIOTECHNOLOGY
$5.38
+0.00% today
Updated 2026-04-29
Market cap
$242.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.24
Dividend yield
—
52W range
$5 – $6
Volume
—
Third Harmonic Bio Inc. (THRD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-19.90%
ROA
-14.60%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $0.00 | $-12.81M | — | — | — |
| 2021 | $0.00 | $-29.61M | — | — | — |
| 2022 | $0.00 | $-37.71M | — | — | — |
| 2023 | $0.00 | $-30.82M | — | — | — |
| 2024 | $0.00 | $45.47M | — | — | — |